Pain for Pfizer--claims of pregabalin patent deemed insufficient

By Smyth, D., Howell, C.

The validity of a second medical use patent for treating pain was challenged on the grounds of lack of inventive step and insufficiency. The latter challenge proved successful, as there was no evidence in the patent making the efficacy of pregabalin against central neuropathic pain plausible.

…read more

Source:: Journal of Intellectual Property Law & Practice